Clinical Trial Update: Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone [Phase 3]

View source ↗

Summary

Phase 3 trial comparing behavioral naltrexone therapy to promote adherence to oral naltrexone versus extended-release injectable depot naltrexone completed and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heroin Dependence
• Opiate Dependence

Drugs mentioned

• Naltrexone (extended-release injectable depot) (naltrexone)
• Naltrexone (oral) (naltrexone)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Opiate Dependence, Heroin Dependence | Phase 3 | Status: COMPLETED | Results posted: 2017-08-25